Cost of Drug vs. Treatment Benefit for Melanoma

Coming hot on the heels of ASCO’s (American Society of Clinical Oncology) annual meeting, Carol Preston, Patient Empowerment Network correspondent, speaks briefly with melanoma expert, Dr. Sapna Patel, assistant professor in the Department of Melanoma Medical Oncology at the University of Texas MD Anderson Cancer Center. The subject of targeted therapies and immuno-therapies is exciting but brings with it the question of cost versus value, particularly from the patient perspective. Dr. Patel explains how she, as a physician, must weigh the cost of treatment against the cost-effectiveness of the therapy, measuring years of survival against cost of financial burden.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo